Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Sort descending Initiative Program Official
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome 5R01CA260761-04 Asad Umar, D.V.M., Ph.D.
Li, Debiao

Cedars-Sinai Medical Center
United States

Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images 5R01CA260955-05 Matthew Young, Ph.D.
Valdimarsdottir, Heiddis

Icahn School Of Medicine At Mount Sinai
United States

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-04 PAR-21-035 (R01 Clinical Trial Required) Marjorie Perloff, M.D.
Kroetz, Deanna L

Ohio State University
United States

Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity 5R01CA261068-06 Rachel Altshuler, Ph.D.
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care 5R01CA261874-04 Eileen Dimond, R.N., M.S.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D.
Huberty, Jennifer Lynne

University Of Texas Hlth Science Center
United States

Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients 5R01CA262041-05 Marjorie Perloff, M.D.
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Christos Patriotis, Ph.D., M.Sc.
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 5R01CA262213-03 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.